Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
lysosomal storage diseases
MeSH D016464 - lysosomal storage diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008661:
Inborn errors metabolism
8 Companies
18 Drugs
$
Success rate
D016464:
Lysosomal storage diseases
1 Company
1 Drug
$
Success rate
D003554:
Cystinosis
5 Companies
2 Drugs
$
Success rate
D009083:
Mucopolysaccharidoses
0 Companies
0 Drugs
Success rate
D015217:
Cholesterol ester storage disease
0 Companies
0 Drugs
Success rate
D020140:
Nervous system lysosomal storage diseases
0 Companies
0 Drugs
Success rate
D044904:
Mannosidase deficiency diseases
0 Companies
0 Drugs
Success rate
D054880:
Aspartylglucosaminuria
0 Companies
0 Drugs
Success rate
D058631:
Pycnodysostosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/1
Phase 2
0
%
0/0
Phase 3
0
%
0/0
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sanofi
Olipudase alfa
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use